EKSO — Ekso Bionics Holdings Balance Sheet
0.000.00%
- $14.55m
- $16.09m
- $17.93m
- 30
- 50
- 62
- 45
Annual balance sheet for Ekso Bionics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 12.9 | 40.4 | 20.5 | 8.64 | 6.49 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.39 | 4.66 | 4.63 | 5.64 | 7.24 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 18.4 | 47.8 | 31 | 20.2 | 18.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.86 | 1.21 | 3.99 | 3 | 2.37 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 20.6 | 49.2 | 40.9 | 28.9 | 26.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.97 | 6.86 | 9.2 | 8.12 | 7.54 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 16.2 | 11.9 | 15.5 | 16.3 | 13.9 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.43 | 37.2 | 25.4 | 12.6 | 12.7 |
| Total Liabilities & Shareholders' Equity | 20.6 | 49.2 | 40.9 | 28.9 | 26.7 |
| Total Common Shares Outstanding |